{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:43:15Z","timestamp":1790678595976,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["seminoncol.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1053\/j.seminoncol.2016.10.003","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T06:31:23Z","timestamp":1477377083000},"page":"598-608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Genetic predisposition to leukemia and other hematologic malignancies"],"prefix":"10.1053","volume":"43","author":[{"given":"Simone","family":"Feurstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Drazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy A.","family":"Godley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2016.10.003_bib1","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1182\/blood-2012-09-457945","article-title":"Identifying familial myelodysplastic\/acute leukemia predisposition syndromes through hematopoietic stem cell transplantation donors with thrombocytopenia","volume":"120","author":"Churpek","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","article-title":"Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia","volume":"23","author":"Song","year":"1999","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib3","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1056\/NEJMoa041331","article-title":"Mutation of CEBPA in familial acute myeloid leukemia","volume":"351","author":"Smith","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib4","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ajhg.2012.03.020","article-title":"Exome sequencing identifies autosomal-dominant SRP72 mutations associated with familial aplasia and myelodysplasia","volume":"90","author":"Kirwan","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib5","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ccell.2015.03.017","article-title":"Inherited and somatic defects in DDX41 in myeloid neoplasms","volume":"27","author":"Polprasert","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib6","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2016-05-670240","article-title":"How I diagnose and manage individuals at risk for inherited myeloid malignancies","volume":"128","author":"The University of Chicago Hematopoietic Malignancies Cancer Risk Team","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajhg.2010.12.006","article-title":"Mutations in the 5\u2032 UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2","volume":"88","author":"Pippucci","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib8","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood-2009-03-208629","article-title":"Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia","volume":"115","author":"Vinh","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib9","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/09537104.2013.818636","article-title":"Development of hairy cell leukemia in familial platelet disorder with predisposition to acute myeloid leukemia","volume":"25","author":"Toya","year":"2014","journal-title":"Platelets"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1053\/j.seminhematol.2014.08.001","article-title":"Inherited predisposition to acute myeloid leukemia","volume":"51","author":"Godley","year":"2014","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2013-03-489344","article-title":"A missense mutation in ANKRD26 segregates with thrombocytopenia","volume":"122","author":"Al Daama","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib12","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1182\/blood-2011-02-336537","article-title":"Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families","volume":"117","author":"Noris","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.3177","article-title":"Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy","volume":"47","author":"Zhang","year":"2015","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib14","doi-asserted-by":"crossref","first-page":"e1005262","DOI":"10.1371\/journal.pgen.1005262","article-title":"Germline ETV6 mutations confer susceptibility to acute lymphoblastic leukemia and thrombocytopenia","volume":"11","author":"Topka","year":"2015","journal-title":"PLOS Genet"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ng.3253","article-title":"Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia","volume":"47","author":"Noetzli","year":"2015","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib16","doi-asserted-by":"crossref","first-page":"11478","DOI":"10.1038\/ncomms11478","article-title":"Common genetic variation in ETV6 is associated with colorectal cancer susceptibility","volume":"7","author":"Wang","year":"2016","journal-title":"Nat Commun"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib17","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1200\/JCO.2008.16.5563","article-title":"Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia","volume":"26","author":"Pabst","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib18","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1182\/blood-2010-09-307280","article-title":"Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity","volume":"117","author":"Taskesen","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13045-014-0055-7","article-title":"Long-term follow-up of cytogenetically normal CEBPA-mutated AML","volume":"7","author":"Pastore","year":"2014","journal-title":"J Hematol Oncol"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib20","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2015-05-647172","article-title":"Disease evolution and outcomes in familial AML with germline CEBPA mutations","volume":"126","author":"Tawana","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib21","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood-2015-10-676098","article-title":"Novel germline DDX41 mutations define families with a lower age of MDS\/AML onset, and lymphoid malignancies","volume":"127","author":"Lewinsohn","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/bjh.13317","article-title":"Haematopoietic and immune defects associated with GATA2 mutation","volume":"169","author":"Collin","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib23","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood-2015-04-641100","article-title":"Genomic analysis of germ line and somatic variants in familial myelodysplasia\/acute myeloid leukemia","volume":"126","author":"Churpek","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3324\/haematol.2013.101303","article-title":"Collaborating constitutive and somatic genetic events in myeloid malignancies: ASXL1 mutations in patients with germline GATA2 mutations","volume":"99","author":"Micol","year":"2014","journal-title":"Haematologica"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/nyas.12346","article-title":"Familial myelodysplastic syndrome\/acute leukemia syndromes: a review and utility for translational investigations","volume":"1310","author":"West","year":"2014","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1172\/JCI78554","article-title":"Telomerase mutations in smokers with severe emphysema","volume":"125","author":"Stanley","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib27","doi-asserted-by":"crossref","first-page":"5607","DOI":"10.1182\/blood-2010-11-322149","article-title":"Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase","volume":"117","author":"Parry","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40291-013-0020-0","article-title":"Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome","volume":"17","author":"Sorrell","year":"2013","journal-title":"Mol Diagn Ther"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib29","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/cncr.29615","article-title":"Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia","volume":"122","author":"Churpek","year":"2015","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib30","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/pbc.24417","article-title":"Identification of TP53 as an acute lymphocytic leukemia susceptibility gene through exome sequencing","volume":"60","author":"Powell","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib31","first-page":"171","article-title":"Trisomy 8: an international study of 70 patients","volume":"13","author":"Riccardi","year":"1977","journal-title":"Birth Defects Orig Art Ser"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1756-8935-6-18","article-title":"Constitutional trisomy 8 mosaicism as a model for epigenetic studies of aneuploidy","volume":"6","author":"Davidsson","year":"2013","journal-title":"Epigenetics Chromatin"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.blre.2010.03.002","article-title":"Pathophysiology and management of inherited bone marrow failure syndromes","volume":"24","author":"Shimamura","year":"2010","journal-title":"Blood Rev"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.beha.2014.10.002","article-title":"Fanconi anemia and the development of leukemia","volume":"27","author":"Alter","year":"2014","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1158\/2159-8290.CD-12-0421","article-title":"Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer","volume":"3","author":"Domchek","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib36","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1182\/blood-2015-03-635599","article-title":"Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice","volume":"127","author":"Vasanthakumar","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1158\/2159-8290.CD-14-1156","article-title":"Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype","volume":"5","author":"Sawyer","year":"2015","journal-title":"Cancer Discov"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/07853890.2014.915579","article-title":"Inherited bone marrow failure syndromes in adolescents and young adults","volume":"46","author":"Wilson","year":"2014","journal-title":"Ann Med"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1399-0004.2007.00923.x","article-title":"Dyskeratosis congenita: a genetic disorder of many faces","volume":"73","author":"Kirwan","year":"2007","journal-title":"Clin Genet"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib40","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/jmedgenet-2015-103292","article-title":"Bone marrow failure and developmental delay caused by mutations in poly(A)-specific ribonuclease (PARN)","volume":"52","author":"Dhanraj","year":"2015","journal-title":"J Med Genet"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib41","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1182\/blood-2014-08-596445","article-title":"Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1","volume":"124","author":"Guo","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib42","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1182\/blood-2008-12-192880","article-title":"Cancer in dyskeratosis congenita","volume":"113","author":"Alter","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib43","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/GIM.0b013e3181f415b5","article-title":"The genetics and clinical manifestations of telomere biology disorders","volume":"12","author":"Savage","year":"2010","journal-title":"Genet Med"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib44","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1182\/blood-2013-09-527127","article-title":"MYSM1 is mutated in a family with transient transfusion-dependent anemia, mild thrombocytopenia, and low NK- and B-cell counts","volume":"122","author":"Alsultan","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib45","doi-asserted-by":"crossref","unstructured":"Bahrami E, Racek T, Witzel M, et al. A human bone marrow failure syndrome caused by a homozygous mutation in MYSM1. Paper presented at the 57th Annual Meeting of the American Society of Hematology; 2015 December 05; Orlando, FL.","DOI":"10.1182\/blood.V126.23.1204.1204"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib46","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1182\/blood-2011-05-352666","article-title":"The critical role of histone H2A-deubiquitinase Mysm1 in hematopoiesis and lymphocyte differentiation","volume":"119","author":"Nijnik","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib47","doi-asserted-by":"crossref","first-page":"36269","DOI":"10.18632\/oncotarget.5915","article-title":"Genetic polymorphisms associated with increased risk of developing chronic myelogenous leukemia","volume":"6","author":"Bruzzoni-Giovanelli","year":"2015","journal-title":"Oncotarget"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib48","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/2040620713489144","article-title":"Inherited predisposition to myeloproliferative neoplasms","volume":"4","author":"Jones","year":"2013","journal-title":"Ther Adv Hematol"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib49","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1200\/JCO.2007.12.6896","article-title":"Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation","volume":"25","author":"Rumi","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3324\/haematol.2009.015941","article-title":"Hereditary myeloproliferative disorders","volume":"95","author":"Skoda","year":"2010","journal-title":"Haematologica"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib51","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.3380","article-title":"Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies","volume":"47","author":"Saliba","year":"2015","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib52","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood-2015-09-668673","article-title":"Germline RBBP6 mutations in familial myeloproliferative neoplasms","volume":"127","author":"Harutyunyan","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib53","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ng.342","article-title":"A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms","volume":"41","author":"Kilpivaara","year":"2009","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib54","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/ajh.23842","article-title":"Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms","volume":"89","author":"J\u00e4ger","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib55","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/leu.2014.48","article-title":"The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms","volume":"28","author":"Oddsson","year":"2014","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib56","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/leu.2013.363","article-title":"Inherited susceptibility to pre B-ALL caused by germline transmission of PAX5 c.547G>A","volume":"28","author":"Auer","year":"2014","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib57","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ng.2754","article-title":"A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia","volume":"45","author":"Shah","year":"2013","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib58","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1182\/blood-2013-05-500850","article-title":"Genetic loss of SH2B3 in acute lymphoblastic leukemia","volume":"122","author":"Perez-Garcia","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib59","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.3324\/haematol.2013.090175","article-title":"Infrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative \u05f3idiopathic\u05f3 erythrocytosis","volume":"98","author":"Spolverini","year":"2013","journal-title":"Haematologica"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib60","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1182\/blood-2013-10-532622","article-title":"Association of a single-nucleotide polymorphism in the SH2B3 gene with JAK2V617F-positive myeloproliferative neoplasms","volume":"123","author":"Lesteven","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib61","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1182\/blood-2010-07-298760","article-title":"Racial disparities in incidence and outcome in multiple myeloma: a population-based study","volume":"116","author":"Waxman","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib62","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/ijc.24514","article-title":"Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden","volume":"125","author":"Kristinsson","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib63","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ng.993","article-title":"Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk","volume":"44","author":"Broderick","year":"2011","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib64","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2141.2012.09244.x","article-title":"Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma","volume":"158","author":"Martino","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib65","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1182\/blood-2013-10-532283","article-title":"Inherited genetic susceptibility to monoclonal gammopathy of unknown significance","volume":"123","author":"Weinhold","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib66","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S1470-2045(09)70234-7","article-title":"Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study","volume":"10","author":"Grass","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib67","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1182\/blood-2011-01-331454","article-title":"Paraproteins of familial MGUS\/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sporadic MGUS\/MM","volume":"118","author":"Grass","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib68","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1002\/ijc.28864","article-title":"Inactivation of protein-phosphatase 2A causing hyperphosphorylation of autoantigenic paraprotein targets in MGUS\/MM is due to an exchange of its regulatory subunits","volume":"135","author":"Preuss","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib69","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1182\/blood-2015-11-680199","article-title":"Exome sequencing reveals recurrent germline variants in patients with familial Waldenstrom macroglobulinemia","volume":"127","author":"Roccaro","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib70","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1182\/blood-2015-04-537498","article-title":"Familial predisposition and genetic risk factors for lymphoma","volume":"126","author":"Cerhan","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib71","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1158\/1055-9965.EPI-08-1037","article-title":"Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development","volume":"18","author":"Morton","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib72","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s12094-015-1379-7","article-title":"Familial hematological malignancies: ASXL1 gene investigation","volume":"18","author":"Hamadou","year":"2016","journal-title":"Clin Transl Oncol."},{"key":"10.1053\/j.seminoncol.2016.10.003_bib73","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1182\/blood-2013-02-469031","article-title":"Development of Hodgkin lymphoma in homozygotic triplets with constitutional deletion in MKL1","volume":"121","author":"Bjorkholm","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib74","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.blre.2008.03.009","article-title":"Immunodeficiency-associated lymphomas","volume":"22","author":"Tran","year":"2008","journal-title":"Blood Rev"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib75","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1182\/blood-2013-05-503383","article-title":"Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren\u2019s syndrome","volume":"122","author":"Nocturne","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib76","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3324\/haematol.2014.113456","article-title":"Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity","volume":"100","author":"Zhang","year":"2015","journal-title":"Haematologica"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib77","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/leu.2013.193","article-title":"Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells","volume":"27","author":"Geyh","year":"2013","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib78","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.leukres.2015.01.013","article-title":"Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors","volume":"39","author":"Chandran","year":"2015","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib79","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature08851","article-title":"Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia","volume":"464","author":"Raaijmakers","year":"2010","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib80","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1182\/blood-2011-03-343467","article-title":"Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts","volume":"118","author":"Blau","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib81","first-page":"e302","article-title":"Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration. Blood","volume":"5","author":"Huang","year":"2015","journal-title":"Cancer J"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib82","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.exphem.2006.10.012","article-title":"Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia","volume":"35","author":"Blau","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib83","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/leu.2008.361","article-title":"Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q\u2212 syndrome","volume":"23","author":"Lopez-Villar","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib84","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature10738","article-title":"Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing","volume":"481","author":"Ding","year":"2012","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib85","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib86","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1182\/blood-2015-08-667063","article-title":"MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance","volume":"126","author":"Kwok","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib87","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/leu.2014.7","article-title":"Whole-exome sequencing of polycythemia vera revealed novel driver genes and somatic mutation shared by T cells and granulocytes","volume":"28","author":"Wang","year":"2014","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib88","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/bmt.2015.117","article-title":"Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes","volume":"50","author":"Peffault de Latour","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib89","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/bjh.12748","article-title":"Response to androgen therapy in patients with dyskeratosis congenita","volume":"165","author":"Khincha","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib90","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood-2013-04-499319","article-title":"ANKRD26-related thrombocytopenia and myeloid malignancies","volume":"122","author":"Noris","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib91","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.10.003_bib92","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1200\/JCO.2008.16.6959","article-title":"Beyond Li Fraumeni syndrome: clinical characteristics of families with p53 germline mutations","volume":"27","author":"Gonzalez","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775416300288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775416300288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T22:28:47Z","timestamp":1601159327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775416300288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0093775416300288"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2016.10.003","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic predisposition to leukemia and other hematologic malignancies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminoncol.2016.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}